Preparation of psoralen polymer–lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells

References

• Acs. (2016). What are the key statistics about breast cancer? [Online]. American Cancer Society. Available at: http://www.cancer.org/cancer/breastcancer/detailedguide/breastcancer-key-statistics [last accessed 4 Feb 2016].
   Google Scholar
• Alfarouk KO, Stock C-M, Taylor S, et al. (2015). Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15:71.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev M, Nativ L, Assaraf YG, Livney YD. (2018). Re-assembled casein micelles for oral delivery of chemotherapeutic combinations to overcome multidrug resistance in gastric cancer. J Mol Clin Med 1:52–61.
   Google Scholar
• Beija M, Salvayre R, Lauth-De Viguerie N, Marty J-D. (2012). Colloidal systems for drug delivery: from design to therapy. Trend Biotechnol 30:485–96.
   PubMed Web of Science ®Google Scholar
• Choi YH, Yu AM. (2014). ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Design 20:793–807.
   PubMed Web of Science ®Google Scholar
• Ciaravino V, Mccullough T, Dayan A. (2001). Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum Exp Toxicol 20:533–50.
   PubMed Web of Science ®Google Scholar
• Dai CL, Fu LW. (2005). The development of the reversal of the tumor multidrug resistance. Chinese Pharmacologic Bull 21:513–8.
   Google Scholar
• Duan R, Li C, Wang F, Yangi J-C. (2017). Polymer–lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma. Colloids Surf B: Biointerfaces 159:880–7.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58.
   PubMed Web of Science ®Google Scholar
• Hao T, Qiao M, Li Z, Chen D. (2008). Progress in the study of pH and temperature sensitive biodegradable block copolymers. Yao Xue Xue Bao = Acta Pharm Sin 43:123–7.
   PubMedGoogle Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. (2013). Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714–26.
   PubMed Web of Science ®Google Scholar
• Hsieh MJ, Chen MK, Yu YY, et al. (2014). Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines. Phytomedicine 21:970–7.
   PubMed Web of Science ®Google Scholar
• Kathawala RJ, Gupta P, Ashby CR Jr, Chen ZS. (2015). The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17.
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Harashima H. (2014). Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharm Res 37:4–15.
   PubMed Web of Science ®Google Scholar
• Kohandel M, Haselwandter CA, Kardar M, et al. (2011). Quantitative model for efficient temporal targeting of tumor cells and neovasculature. Comput Math Method Med 2011:1–10.
   Web of Science ®Google Scholar
• Li Q, Cai T, Huang Y, et al. (2017). A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials 7:122.
   Web of Science ®Google Scholar
• Liu Q, Li Q, Huang Y, et al. (2017). Preparation and multidrug resistance reversal study of matrine-loaded solid lipid nanoparticles. J Biomater Tissue Eng 7:582–9.
   Web of Science ®Google Scholar
• Liu W, Zhai Y, Heng X, et al. (2016). Oral bioavailability of curcumin: problems and advancements. J Drug Target 24:694–702.
   PubMed Web of Science ®Google Scholar
• Meng J, Guo F, Xu H, et al. (2016). Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep 6:22390.
   PubMed Web of Science ®Google Scholar
• Mishra BJ, Kaul A, Trivedi P. (2015). L-cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Drug Deliv 22:214–22.
   PubMed Web of Science ®Google Scholar
• Peetla C, Stine A, Labhasetwar V. (2009). Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm 6:1264–76.
   PubMed Web of Science ®Google Scholar
• Pokharkar VB, Jolly MR, Kumbhar DD. (2015). Engineering of a hybrid polymer–lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: Physicochemical, molecular, microstructural, and stability evaluation. Eur J Pharm Sci 71:99–111.
   PubMed Web of Science ®Google Scholar
• Sah AK, Suresh PK. (2017). Loteprednol etabonate nanoparticles: optimization via Box–Behnken design response surface methodology and physicochemical characterization. Curr Drug Deliv 14:676–89.
   PubMed Web of Science ®Google Scholar
• Souto E, Müller R. (2008). Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®). Int J Cosmet Sci 30:157–65.
   PubMedGoogle Scholar
• Van Kuilenburg AB, Maring JG. (2013). Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients. Pharmacogenomics 14:799–811.
   PubMed Web of Science ®Google Scholar
• Van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405–14.
   PubMed Web of Science ®Google Scholar
• Wan S, Sun Y, Qi X, Tan F. (2012). Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech 13:159–66.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng K, Han Y, et al. (2016). Effects of psoralen as an anti-tumor agent in human breast cancer MCF-7/ADR cells. Biol Pharm Bull 39:815–22.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Yuet K, Zhang L, et al. (2010). ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine 5:361–8.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, et al. (2014). Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett 347:159–66.
   PubMed Web of Science ®Google Scholar
• Wu XY. 2016. Strategies for optimizing polymer–lipid hybrid nanoparticle-mediated drug delivery. Expert Opinion on Drug Delivery 13:609–612.
   Google Scholar
• Yang XZ, Dou S, Wang YC, et al. (2012). Single-step assembly of cationic lipid–polymer hybrid nanoparticles for systemic delivery of siRNA. Acs Nano 6:4955.
   PubMed Web of Science ®Google Scholar
• Yuan F, Bai GG, Miao YJ, et al. (2014). Research progress in Chinese materia medica reversing multidrug resistance on tumor cells. Chinese Traditional Herbal Drugs 45:857–63.
   Google Scholar
• Yuan Y, Cai T, Xia X, et al. (2016). Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Drug Deliv 23:3350–7.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Cai P, Zhang T, et al. (2016). Polymer–lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin–mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. Nanomed: Nanotechnol Biol Med 12:1279–90.
   PubMed Web of Science ®Google Scholar
• Zhao X, Chen Q, Li Y, et al. (2015). Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm 93:27–36.
   PubMed Web of Science ®Google Scholar